Clinical significance of heat shock protein-70 expression in bladder cancer

Urology

Volumn 61, Issue 3, 2003, Pages 677-680

  Syrigos, Konstantinos N ^a   Harrington, Kevin J ^b   Karayiannakis, Anastasios J ^b   Sekara, Eleutheria ^b   Chatziyianni, Emmy ^b   Syrigou, Ekaterini I ^b   Waxman, Jonathan ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; POLYCLONAL ANTIBODY;

AGED; ARTICLE; BIOTINYLATION; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL STUDY; CORRELATION ANALYSIS; CYSTITIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS;

AGED; ANIMALS; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CYSTITIS; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RABBITS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0037334496     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02289-6     Document Type: Article

References (24)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics. CA Cancer J Clin. 48:1998;6-29.
2. Heiken J.P., Forman H.P., Brown J.J., et al. Neoplasms of the bladder, prostate and testis. Radiol Clin North Am. 32:1994;81-98.
3. Silverman D.T., Rothman N., Devesa S.S. Epidemiology of bladder cancer. Syrigos K.N., Skinner D.G. Bladder Cancer Biology, Diagnosis, and Management . 1999;11-55 Oxford University Press, London.
4. Abel P.D., Henderson D., Bennett M., et al. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol. 62:1988;339-342.
5. Verbeke P., Fonager J., Clark B.F., et al. Heat shock response and ageing mechanisms and applications . Cell Biol Int. 25:2001;845-857.
6. Garrido C., Gurbuxani S., Ravagnan L., et al. Heat shock proteins endogenous modulators of apoptotic cell death . Biochem Biophys Res Commun. 286:2001;433-442.
7. Kohler G., Veelken H., Rosenthal F., et al. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line. Anticancer Res. 17:1997;3225-3231.
8. Koomagi R., Stammler G., Manegold C., et al. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett. 110:1996;129-136.
9. Lee C.S., Montebello J., Rush M., et al. Overexpression of heat shock protein (HSP) 70 associated with abnormal p53 expression in cancer of the pancreas. Zentralbl Pathol. 140:1994;259-264.
10. Liu F.F., Miller N., Levin W., et al. The potential role of HSP70 as an indicator of response to radiation and hypothermia treatments for recurrent breast cancer. Int J Hypertherm. 12:1996;197-208.
11. Locke M., Noble E.G. Stress proteins the exercise response . Can J Appl Physiol. 20:1995;155-167.
12. Mostofi FK, Sobin LH, and Torloni H: Histological typing of urinary bladder tumors, in International Histological Classification of Tumors, 10th ed. Geneva, World Health Organization, 1983.
13. Vargas-Roig L.M., Fanelli M.A., Lopez L.A., et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev. 21:1997;441-451.
14. Murakami T., Ohmori H., Katoh T., et al. Cadmium causes increases of N-myc and multidrug-resistance gene mRNA in neuroblastoma cells. Sangyo Ika Daigaku Zasshi. 13:1991;271-278.
15. Patel B., Khaliq A., Jarvis-Evans J., et al. Hypoxia induces HSP 70 gene expression in human hepatoma (HEP G2) cells. Biochem Mol Biol Int. 36:1995;907-912.
16. Samali A., Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp Cell Res. 223:1996;163-170.
17. Stammler G., Pommenerke E.W., Masanek U., et al. Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation. J Exp Ther Oncol. 1:1996;39-48.
18. Stein J.P., Skinner D.G. Clinical presentation and investigation of bladder cancer. Syrigos K.N., Skinner D.G. Bladder Cancer Biology, Diagnosis, and Management . 1999;167-179 Oxford University Press, London.
19. Multhoff G., Botzler C., Wiesnet M., et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer. 61:1995;272-279.
20. Syrigos K.N., Harrington K.J., Pignatelli M. Role of adhesion molecules in bladder cancer an important part of the jigsaw . Urology. 53:1999;428-434.
21. Syrigos K.N., Deonarian D.P., Epenetos A.A. The use of monoclonal antibodies for the diagnosis and treatment of bladder cancer. Hybridoma. 18:1999;219-224.
22. Syrigos K.N., Karayiannakis A.J., Zbar A. Mucins as immunogenic targets in cancer. Anticancer Res. 19:1999;5239-5244.
23. Syrigos K.N., Kawaga M., Krausz T., et al. Intravesical administration of radiolabelled HMFG1 a preclinical study . Acta Oncol. 38:1999;379-382.
24. Syrigos K.N., Epenetos A.A. Antibody directed enzyme prodrug therapy (ADEPT) a review of the experimental and clinical considerations . Anticancer Res. 19:1999;605-614.